Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Washington, DC keessatti
Qorannoo 22 Luukemiya Limfoositiikii Keessummaa f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- American Oncology Partners of Maryland Pa, Bethesda · Miili 7 fagaatti
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Namoota walitti qabaa jiraSadarkaa 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · Miili 7 fagaatti
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
- GC2202 Study Site 111, Bethesda · Miili 7 fagaatti
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Namoota walitti qabaa jiraSadarkaa 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners of Maryland Pa, Bethesda · Miili 7 fagaatti
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Namoota walitti qabaa jiraSadarkaa 2
- Maryland Oncology Hematology, Silver Spring · Miili 7 fagaatti
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners of Maryland, PA, Bethesda · Miili 7 fagaatti
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Namoota walitti qabaa jiraSadarkaa 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · Miili 7 fagaatti
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Namoota walitti qabaa jiraSadarkaa 1/2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- National Institute of Health, Bethesda · Miili 7 fagaatti
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- American Oncology Partners, PA, Bethesda · Miili 7 fagaatti
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · Miili 7 fagaatti
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · Miili 7 fagaatti
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 18
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 14
- Nashville, TNQorannoo 13
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Saree OljooQorannoo 46
- Kansara MetastatikiiQorannoo 43
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.